Cynthia Comella to Botulinum Toxins
This is a "connection" page, showing publications Cynthia Comella has written about Botulinum Toxins.
Connection Strength
3.492
-
Systematic review of botulinum toxin treatment for oromandibular dystonia. Toxicon. 2018 Jun 01; 147:96-99.
Score: 0.606
-
Botulinum Toxin Treatment of Cervical Dystonia. Semin Neurol. 2016 Feb; 36(1):47-53.
Score: 0.527
-
Treatment of focal dystonias with botulinum neurotoxin. Toxicon. 2009 Oct; 54(5):628-33.
Score: 0.321
-
The treatment of cervical dystonia with botulinum toxins. J Neural Transm (Vienna). 2008; 115(4):579-83.
Score: 0.298
-
Treatment of cervical dystonia with botulinum toxins. Eur J Neurol. 2006 Feb; 13 Suppl 1:16-20.
Score: 0.263
-
Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology. 2005 Nov 08; 65(9):1423-9.
Score: 0.259
-
Botulinum toxins in neurological disease. Muscle Nerve. 2004 May; 29(5):628-44.
Score: 0.233
-
Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy? Toxicon. 2018 Jun 01; 147:89-95.
Score: 0.147
-
Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia. Parkinsonism Relat Disord. 2014 Apr; 20(4):405-8.
Score: 0.114
-
Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013 Nov; 28(13):1775-83.
Score: 0.110
-
Dysphagia after botulinum toxin injections for spasmodic torticollis: clinical and radiologic findings. Neurology. 1992 Jul; 42(7):1307-10.
Score: 0.103
-
Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology. 1992 Apr; 42(4):878-82.
Score: 0.101
-
Jaw-opening dystonia: Quality of life after botulinum toxin injections. Ear Nose Throat J. 2011 Feb; 90(2):E9.
Score: 0.093
-
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 May 06; 70(19):1699-706.
Score: 0.077
-
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology. 2006 Dec 26; 67(12):2233-5.
Score: 0.070
-
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology. 1999 Oct 22; 53(7):1431-8.
Score: 0.043
-
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology. 1999 Oct 22; 53(7):1439-46.
Score: 0.043
-
[Botulin toxin: principles of action and neurological indications]. Presse Med. 1997 Feb 01; 26(2):96-100.
Score: 0.035
-
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol. 1993 Jun; 16(3):205-10.
Score: 0.027
-
New approaches in the treatment of the dystonias. Klin Wochenschr. 1990 Oct 03; 68(19):935-41.
Score: 0.023